Dashboard
Poor long term growth as Operating profit has grown by an annual rate -167.39% of over the last 5 years
The company has declared Negative results for the last 12 consecutive quarters
Risky - Negative Operating Profits
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Electronics & Appliances
USD 265 Million (Micro Cap)
NA (Loss Making)
NA
6.63%
0.32
-9.32%
0.38
Total Returns (Price + Dividend) 
Methode Electronics, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
Is Methode Electronics, Inc. technically bullish or bearish?
As of 10 July 2025, the technical trend for Methode Electronics, Inc. has changed from mildly bullish to mildly bearish. The weekly MACD remains mildly bullish, but the daily moving averages indicate a mildly bearish stance. The Bollinger Bands show a bullish signal on the weekly chart but are mildly bearish on the monthly chart. The KST is bearish on the weekly timeframe while mildly bullish monthly, and the Dow Theory indicates a mildly bearish trend on the monthly scale. Overall, the technical stance is mildly bearish. In terms of performance, the stock has returned -29.35% year-to-date compared to the S&P 500's 12.22%, and over the past year, it has declined by 24.00% versus the S&P 500's 17.14%....
Read MoreIs Methode Electronics, Inc. overvalued or undervalued?
As of 7 December 2023, the valuation grade for Methode Electronics, Inc. has moved from expensive to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued based on its current metrics, particularly given its negative return on equity (ROE) of -4.90% and return on capital employed (ROCE) of -0.82%. The price-to-book value stands at a low 0.43, suggesting that the stock is trading significantly below its book value, which could imply undervaluation in certain contexts, but the overall financial performance points to risks. In comparison to peers, Methode's EV to EBITDA ratio is 10.83, while RxSight, Inc. has a much lower EV to EBITDA of -3.5473, highlighting a stark contrast in operational efficiency. The company's dividend yield of 6.63% may attract income-focused investors, but the underlying losses and negative profitability ratios raise concerns. Des...
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jan 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 66 Schemes (67.3%)
Held by 94 Foreign Institutions (11.53%)
Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ
QoQ Growth in quarter ended Apr 2025 is 7.17% vs -18.01% in Jan 2025
QoQ Growth in quarter ended Apr 2025 is -96.53% vs -800.00% in Jan 2025
Annual Results Snapshot (Consolidated) - Apr'25
YoY Growth in year ended Apr 2025 is -5.96% vs -5.52% in Apr 2024
YoY Growth in year ended Apr 2025 is 49.23% vs -259.92% in Apr 2024






